Stockreport

Vaccinex to Present at the Oppenheimer 31st Annual Healthcare Conference

Vaccinex, Inc.  (VCNX) 
PDF ROCHESTER, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treat [Read more]